Andreessen Horowitz Converts Preferred and Buys $5M in Scribe IPO
SCTX is trading near its 52-week low of $17.305 (6.9% above the low).
Summary
Andreessen Horowitz's life sciences funds converted preferred stock and bought $5 million in Scribe Therapeutics' IPO, signaling conviction from a marquee investor.
Key Events · Ownership and Investor Activity · SCTX
-
Preferred Stock Conversion
Immediately before the IPO closed, AH Bio Fund II and III converted 16,281,347 shares of Series A and B Preferred Stock into 2,749,392 common shares, using a 5.9218-for-one ratio.
-
$5M IPO Purchase
At $15.00 per share, the funds acquired 333,333 common shares in the IPO for a total of $4,999,995, lifting their indirect holdings to 2,385,075 shares.
-
Post-IPO Stake
Following the transactions, the Andreessen Horowitz entities indirectly hold 2,385,075 common shares, representing a significant ownership position in the newly public company.
-
Marquee Investor Endorsement
The conversion and purchase by a top-tier venture capital firm reinforces confidence in Scribe Therapeutics following its upsized $128.7 million IPO priced at the high end of the range.
Analysis · SCTX · Life Sciences
Andreessen Horowitz's life sciences funds converted 16.3 million preferred shares into 2.75 million common shares and bought an additional 333,333 shares at the $15.00 IPO price, investing $5 million. This is a strong endorsement from a top-tier venture firm, coming just days after the company's upsized IPO. The conversion and purchase together represent a significant commitment, though the 10% owner status tempers the signal slightly — it's a financial investor doubling down, not an operator. The filing provides the first detailed look at the firm's post-IPO stake.
At the time of this filing, SCTX was trading at $18.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $297.1M. The 52-week trading range was $17.31 to $22.75. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.